Abstract. Neurotrophins are well known for their physiological role as key modulators of neuronal survival, neurite outgrowth, and synaptic connectivity during development and into adulthood. Moreover, neurotrophins are potent agents, ameliorating neuronal degeneration in many model systems for neurological diseases. However, a causal role for mutations in neurotrophins or neurotrophin receptors in human neurodegenerative diseases has been largely lacking. As neurotrophin receptors are located at synapses and as their signaling involves the neuronal nucleus, they need to bridge tantalizing distances in order to retrogradely communicate their survival signals. On the other hand, anterogradely transported neurotrophins are released at the synapse and act on postsynaptic cells. Antero-and retrograde signaling and trafficking is an emerging focus of interest in neurotrophin research. Some neurodegenerative diseases are known to affect transport of organelles. Thus, it appears likely that neurodegeneration could be caused by ''indirect'' effects on neurotrophin trafficking and, hence, signaling. In this review we summarize recent work on neurotrophins in neurodegenerative diseases with special focus on possible implications of disturbed trafficking of organelles and retrograde axonal signaling.
INTRODUCTION
Nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4/5 (NT-4/5) comprise the mammalian neurotrophins, a family of structurally related dimeric proteins that play a crucial role in the survival, differentiation, neurite outgrowth, and maintenance of specific neuronal populations in the peripheral and central nervous system (1) This relatively simple scheme is complicated by the fact that alternative splicing and/or post-translational processing results in at least 2 isoforms of each neurotrophin and each neurotrophin receptor which shows different interactions (2) . Adding to the complexity, neurons often produce more than one neurotrophin receptor, encounter more than one neurotrophin, and express one or more neurotrophins themselves (3) . Moreover, neuronal survival promoting effects have also been demonstrated for many proteins other than neurotrophins, most notably the members of the glial cell line-derived neurotrophic factor (GDNF) and neurocytokine (e.g. ciliary neurotrophic factor, interleukin-6, and cardiotrophin-1) families. Still, as demonstrated by in vivo knockout experiments (see below), neurotrophins are required for the maintenance of the complete set of specific neuronal cell populations during embryonic development.
The MAPK and PI3K pathway are induced downstream of Trk receptors, resulting in the activation of transcription factors including CREB (1, 4) . Trk signaling in general promotes neuronal survival, while p75NTR has been found to enhance NGF/TrkA signaling at low NGF concentrations or to signal independently of Trks (2, 5) . Trk-independent p75NTR signaling can either induce survival or apoptotic death of certain neuronal populations (2, 5) . Apparently, high levels of p75NTR expression favor the route to apoptosis, whereas low levels of p75NTR confer survival of a neuron upon neurotrophin exposure (2, 5) .
In addition, similar to neurotransmitters, neurotrophins are transported anterogradely to synapses and depolarize postsynaptic sites via TrkB by opening ion channels (6) . The resulting calcium waves and activation of CaM Kinase IV leads to activation of CREB (7) . This synaptic activity of neurotrophins appears to be essential for synaptic plasticity and memory formation, because hippocampal neurons of mice lacking BDNF showed defects in long-term potentiation (1) .
Binding of neurotrophins to Trks induces internalization of the ligand/receptor complexes, giving rise to ''signaling endosomes,'' which undergo retrograde transport within neurites. Disturbances of axonal transport are associated with neurodegenerative diseases (8, 9) , potentially because of decreased retrograde flow of neurotrophic signaling endosomes.
Deficits in the supply or utilization of neurotrophic factors were suggested 20 years ago as a potential cause of neurodegenerative disorders such as Alzheimer disease (AD), Parkinson disease (PD), and amyotrophic lateral sclerosis (ALS) (10, 11) . This hypothesis was based on the observation that-at least in the early stages of these diseases-degeneration is largely restricted to certain neuronal populations such as cholinergic CNS neurons in AD, dopaminergic neurons in PD, motor neurons in ALS, and striatal neurons in Huntington disease. Selective neurodegeneration might be the consequence of a deficit in trophic factors provided by particular target areas. In addition, because simultaneous expression of both the neurotrophic ligand and its receptor has been reported for a number of neuronal subpopulations, disturbances in such auto-and paracrine loops might contribute to neurodegeneration. In this review we summarize some of the recent evidence supporting the view that alterations in neurotrophic factor and neurotrophic factor receptor expression, trafficking, and function contribute to neuronal damage in common neurodegenerative diseases.
Role of Neurotrophins during Development
Neurons and the targets they innervate develop coordinately. Target tissue produced neurotrophins are critical for the survival of innervating neurons. Neurons that fail to innervate the appropriate target tissue during development degenerate by apoptosis. Retrograde signaling of neurotrophins is a central point of this process. The signal has to be conveyed retrogradely over long distances within the neuron from the axon tip to the nucleus. A vast number of neurons are initially generated early in development (12) . During the subsequent period of naturally occurring programmed cell death the axon-tips of these neurons are thought to compete for uptake of neurotrophic factors (13) . Presumably, only small, limited amounts of these proteins are produced by the target tissues. Thus, not all neurons encounter sufficient amounts of these factors, meaning that many of them will die since their survival crucially depends on specific neurotrophic proteins at this time (14) . Neurons with erroneous or sub-optimal connections will encounter insufficient amounts of trophic factors and degenerate by apoptosis. In keeping with this hypothesis, mice lacking the pro-apoptotic key proteins caspase-3 andϪ9 show a dramatic phenotype characterized by an impressive excess of neurons (15) . Hence, neuronal apoptosis might be essential for controlled modeling of the nervous system during development.
Are Neurotrophins Important for Survival of
Adult Neurons?
Results from conventional knock-out mice demonstrated that neurotrophins are powerful regulators of neuronal survival during development (14) . But are neurotrophins also important for the survival of adult neurons, far beyond the time window in which axons have engaged their targets and the period of naturally occurring neuronal cell death? This is an important question when considering a causal relationship between neurodegenerative diseases and neurotrophins, given that most neurodegenerative diseases occur in rather advanced age. To this end, a recent study used inducible knock-out technology to explore this issue (16) and concluded that TrkB signaling is indeed of major importance for the maintenance of specific neuronal populations in the adult neocortex. In line with this, chronic treatment of adult rodents with anti-NGF antibodies induced a marked but slow degeneration of peripheral sympathetic neurons (17) . Thus, 2 different experimental approaches demonstrated that at least some neuronal populations are dependent on neurotrophin signaling for their survival during adulthood.
Surprisingly, degeneration of adult neurons in these studies occurred at a much slower pace than degeneration during embryonic or early postnatal development (i.e. weeks compared to days) (14) . This is reminiscent of neurodegenerative diseases in humans, which are chronic and slow. Moreover, several studies suggest that mutations or polymorphisms in neurotrophin genes are linked to neurodegenerative diseases in humans. For example, certain polymorphisms of the BDNF gene have been linked to AD (18, 19) and PD (20) . In addition, early onset of rodent and human motor neuron disease was associated with CNTF gene mutations (21) . Mutations of other proteins relevant for neurotrophic factor signaling might indirectly lead to a more pronounced effect.
Expression of Neurotrophins and their Receptors in
Normal and Diseased CNS
The picture of the normal expression and transport pattern of neurotrophins and their receptors and its alteration in neurodegenerative diseases is still evolving. The current state of knowledge has been reviewed extensively in recent articles and will therefore be only briefly summarized here (22-25; Table) . Expression of all neurotrophins by distinct populations of neurons and glia has been detected in various regions of the normal cerebral grey matter. More specifically, NGF and BDNF are expressed by several subsets of neocortical neurons. BDNF probably acts on such cortical neurons via an autocrine loop, because TrkB is expressed simultaneously by neocortical neurons. Similarly, substantia nigra neurons have been reported to be immunoreactive for NGF/TrkA, BDNF/ TrkB and NT-3/TrkC, and spinal cord motor neurons were stained for BDNF/TrkB and NT-3/TrkC, again suggesting autocrine loops of neurotrophic stimulation already at work in normal tissue (26, 27) .
NGF, or rather its precursor proNGF (28) (see below), is increased in the cortex of AD patients, whereas cortical BDNF and TrkB levels are apparently reduced in these patients (29) (30) (31) . TrkA expression appears to be reduced in AD neocortex and nucleus basalis Meynert (NBM), as is p75NTR expression in the NBM (22, 33) . NGF is transported retrogradely from the neocortex to the NBM and other target areas. BDNF has been found to be transported retrogradely between many distinct cortical locations, again including trafficking from the neocortex to the NBM as well as from various sources to hippocampal neurons. These trophic connections might be of special importance for AD pathophysiology (see below). In astrocytes of AD cortex, TrkA immunoreactivity was increased (34) and BDNF and TrkB labeling was decreased (35) compared to controls, pointing to yet another possible site of pathophysiological significance of neurotrophins in AD.
BDNF travels anterogradely from the amygdala to the stria terminalis and from neocortex and substantia nigra to the striatum. Interestingly, BDNF was found in neurites, but not in neuronal perikarya of the striatum, and striatal neurons do not express BDNF mRNA (36) . Still, striatal neurons produce TrkB. Therefore, these neurons probably receive anterograde trophic input via corticoand nigrostriatal axons (36) . This trophic connection might be disturbed in Huntington disease (see below).
Neurotrophins and their receptors have been detected immunohistochemically in the majority of substantia nigra neurons (22, 26) . Levels of NGF and BDNF as well as of GDNF and CNTF have been found to be decreased in PD substantia nigra neurons (22) (23) (24) .
Expression of BDNF and activation of TrkB as measured by the levels of phosphorylated TrkB was reported to be reduced in the remaining spinal motoneurons in cases of ALS compared to normal controls (27, 37, 38) . Immunoreactivity for NGF and TrkA, on the other hand, was increased in these neurons compared to normal control motoneurons, indicating a phenotypic switch during the course of the disease (27) . Interestingly, a recent autopsy study found increased levels of all 4 neurotrophins both on the mRNA and protein level in the biceps brachii muscle of 15 ALS patients compared to controls, suggesting that decreased neurotrophin expression by skeletal muscle fibers is not the primary cause of ALS (39).
These results do not exclude the possibility, however, that insufficient retrograde trafficking or signaling of neurotrophins might contribute to motor neuron degeneration.
Organelle Trafficking in Neurons
Although the structure and activity of synapses is variable and subjected to input-dependent changes (''synaptic plasticity'') (40), the single neurons are considered to be postmitotic. This implies that mutations with longterm effects preferentially damage the nervous system. Neurons' long processes (axons as well as long, numerous dendrites representing the trafficking and communication infrastructure) might be considered the ''Achilles' heel'' of the neuron. Hence, it is reasonable to assume that pathological processes affecting the flow of organelles within neurites might indirectly affect the communication between synapses and cell bodies. In other words, correct organelle trafficking is likely to be essential for the functional integrity of nerve cells.
Thus, it appears important to briefly summarize the basic trafficking pathways within mammalian cells (Fig.  1) . Using the classical biosynthetic pathway, newly synthesized proteins move through the endoplasmic reticulum and the Golgi apparatus; eventually, vesicles containing the newly synthesized proteins fuse with the plasma membrane and release their content into the medium. In the case of surface receptors, these proteins are integrated into the membrane. Cells not only release but also ''ingest'' substances from their environment (endocytosis). Using the ''classic'' endocytotic pathway, ligands bind to cell surface receptors and trigger their internalization via clathrin-coated pits, giving rise to clathrin-coated vesicles. These vesicles mature and eventually become ''early endosomes'' (also called ''sorting endosomes''), which are considered to be a major ''trafficking checkpoint'' (41) .
There are 2 principal trafficking pathways downstream of early endosomes. First, internalized ligands and receptors can return to the membrane and re-release their ligand (recycling). The prototypical ligand/receptor system 343 NEUROTROPHINS AND NEURODEGENERATIVE DISEASES J Neuropathol Exp Neurol, Vol 62, April, 2003 for the study of ''recycling endosomes'' is transferrin/ transferrin receptor. On the other hand, ligands and receptors might join the trafficking pathway leading to multivesicular bodies (MVBs) (often also called ''late endosomes'') and finally are degraded in lysosomes.
What determines whether a ligand or receptor is sorted to either of these 2 pathways? Previous studies found that the tyrosine kinase activity of certain receptors (such as the epidermal growth factor, EGF, receptor) is important for their sorting to the degradative pathway and their escape from the recycling pathway, which is regarded as the ''default pathway'' of internalization (41) . Interestingly, ubiquitination of surface receptors recently emerged as a major sorting signal towards MVBs and lysosomes (42) .
Neurons add another layer of complexity to this scheme as they are polarized cells and can be subdivided into 2 different domains, the axonal and the somatodendritic compartment. Sorting of secretory or internalized proteins to and from these 2 compartments appears to be subjected to tight regulation, which is not yet completely understood. However, it is known that MVBs as well as recycling endosomes are present in axons as well as in dendrites (43) .
Retrograde Signaling by Neurotrophins and Their Receptors
According to the classical neurotrophin hypothesis, axons encounter their trophic factors within target tissues, which might be blood vessels in case of sympathetic neurons or the hippocampus in the case of basal forebrain cholinergic neurons (44) . The question arises how these receptors subsequently transmit their signal backwards to the nucleus. Regarding the Trk receptor signaling from axon tip to cell body, this enormous distance is thought to be bridged via 2 mechanisms, which do not seem to be mutually exclusive. First, this signaling could happen via a relatively slow retrograde movement of neurotrophin containing ''signaling endosomes'' that serve as platforms to move the downstream signaling complex necessary to activate transcription factors from one location, the synapse, backwards to a remote location, the cell body. This idea was first proposed by Beattie et al (45) . Secondly, more controversially discussed (46), retrograde neurotrophin signaling may occur via a rapid retrograde signaling mechanism(s) not involving retrograde transport of ligand or receptors (47) .
What is known about mechanisms of retrograde transport of endosomes after receptor internalization at axon tips? Cargo vesicles within neurites are known to move along microtubules (48) . Their movement is achieved by molecular motors, such as dynein and kinesin, which connect vesicles and microtubules while propelling the vesicle in an ATP-dependent manner into either the anterograde (kinesin) or retrograde (dynein) direction (49, 50) .
Which findings support the idea that neurotrophins signal via retrograde transport of vesicles? Most importantly, Mobley and coworkers purified vesicles from NGF-stimulated neurons containing NGF and activated TrkA that could activate a purified transcription factor (45, (51) (52) (53) . In addition, Hyano et al found a direct interaction between the cytoplasmic domain of TrkB and the retrograde motor protein dynein light chain (54) . Moreover, the well-established microtubule disrupting drug colchicine inhibits retrograde flow of GFP-tagged TrkB within the neurites of transfected sensory neurons (55) . Biochemical studies performed in vitro showed that terminal-derived TrkA arrives in cell bodies in complex with NGF (56). Internalized iodinated NGF and endogenous phosphorylated TrkA as well as p75NTR receptors were found within vesicles of peripheral nerve axons by in vivo immunoelectron microscopy; in addition, endogenous NGF, p75NTR, and TrkA accumulate distal to nerve ligations in vivo within vesicular structures (5). Thus, the available experimental data strongly suggest that signaling endosomes containing neurotrophin receptors and use wellcharacterized axonal transport pathways. The receptors are internalized via clathrin-coated pits. The resulting clathrin-coated vesicles represent platforms containing all necessary features to activate pro-survival transcription factors. The receptors are linked to the retrograde motor dynein, and microtubules are used as a guideline to reach the cell bodies.
This hypothesis is tempting since it combines well established models of endocytosis and axonal transport; however, less orthodox mechanisms might also be involved (57) . In support of alternative ways of neurotrophin signaling, McInnis et al reported that a retrograde wave of protein tyrosine phosphorylation along axon plasma membranes preceded the physical retrograde transport of NGF; moreover, NGF can promote survival of sympathetic neurons in vitro without physical internalization and retrograde transport of NGF or TrkA (47) . Another group reported that cell surface Erb-B1 receptors phosphorylate and activate each other in a wave-like manner along the cell membrane of transfected cells (58) . One is tempted to speculate that the same mechanism might also be involved in the fast retrograde signaling of neurotrophins. However, these experiments have been performed under (potentially) nonphysiological conditions in which receptor tyrosine kinases were overexpressed by transfection, or in which NGF internalization was blocked by covalent attachment to beads. A recent report on ErbB-4 receptor tyrosine kinases proposes yet another potential mechanism (59) . Activated receptors are cleaved by proteases releasing catalytically active phosphorylated cytoplasmic fragments from the membrane that undergo translocation to the nucleus. This process has been called RIP (regulated intermembrane proteolysis). Intriguingly, proteolytical cleavage of TrkA and Proteins produced in the endoplasmic reticulum (ER) are processed in the Golgi apparatus and shuttled to the cell surface. Membrane proteins such as neurotrophin receptors stay in the plasma membrane whereas neurotrophins are released into the extracellular space. A special form of this trafficking is the anterograde transport of BDNF to the synapse within the axon. Ligands bind to and activate receptors on the cell surface. The active ligand/receptor complex is taken up in clathrin coated pits, which mature into early endosomes. These organelles can travel long distances retrogradely within the cell containing active ligand/receptor complexes. Ubiquitination (Ub) may target receptors to multivesicular bodies (MVB), and to degradation in lysosomes. Nonubiquitinated ligand and/or receptor might be shuttled back to the cell surface in recycling endosomes. p75NTR has indeed been reported (5) . Moreover, a recent paper by Tsui-Pierchala et al widens the scope of possible signaling and trafficking pathways: NGF might trans-activate other receptor tyrosine kinases that subsequently may undergo retrograde transport, potentially as cleaved activated cytoplasmic domains (60) . Taken together, the currently available evidence suggests that retrograde Trk signaling of neurotrophins is at least in part mediated by retrogradely moving endosomes derived from clathrincoated pits. However, alternative pathways of retrograde signaling appear possible. There is currently agreement that surface TrkA receptors activate the Akt pathway, whereas the MAPK pathway is activated from endosomes (47, 61) .
Does Disturbed Trafficking of Organelles Containing
Neurotrophins or their Receptors Contribute to Neurodegeneration?
In recent years, we witnessed the accumulation of a wealth of novel data regarding patho-physiological mechanisms in neurodegenerative diseases. Some studies pointed towards disturbed ''trafficking'' of organelles as a cause for some of these devastating diseases. The question arises whether disturbed trafficking of organelles might indirectly lead to disturbed retrograde pro-survival signaling of neurotrophins and their receptors (10, 11) . We want to discuss this hypothesis in light of the most recent findings of trafficking defects as causes for neurodegenerative diseases and will attempt to align both fields with each other.
Maybe the most obvious case in point is Niemann Pick Disease C. Mutations in the gene coding for NPC1 (Niemann Pick disease C gene 1) cause pathological accumulation of lipids in endocytic organelles and progressive neurodegeneration. NPC1 is required for cholesterol shuttling between organelles; therefore, cholesterol accumulates in late endosomes/MVBs in affected cells. It was found that the neuropathology in NPC1 cells results, at least in part, from striking defects in late endosomal tubulovesicular trafficking (62) . Intriguingly, it was also reported that TrkB signaling is diminished in these neurons (63) . No study so far has evaluated the sorting of growth factor receptors in diseased cells, but as it is known that MVBs play a pivotal role in the MAPK signaling of other growth factor receptors (such as EGFR), one is tempted to speculate that a lipid-jam induced block of TrkB receptor trafficking from the surface to lysosomes might affect its signaling.
Another example of a neurodegenerative disease in which disturbed growth factor trafficking might be involved is Huntington disease. This illness is characterized by the selective loss of striatal medium-sized neurons. It is caused by PolyQ expansion mutations of huntingtin, a 350 kDa protein that is expressed in many tissues, but highly enriched in cerebral cortex and striatum. In neurons, huntingtin is present in neurites and associated with vesicles and microtubules (64) . Intriguingly, it was found that overexpression of PolyQ expanded (but not normal) huntingtin leads to dramatic attenuation of NGF-induced signaling and neurite outgrowth (65) in PC12 cells. This finding implies mutated huntingtin as relevant for neurotrophin signaling, but is there also evidence that might imply huntingtin in trafficking of growth factor receptors? HAP1 (huntingtin-associated protein 1) and HIP14 (huntingtin interactin protein 14) are two of a number of proteins that interact with huntingtin (66, 67) . It was described that HAP1 binds (directly or indirectly) to Hrs, an important protein involved in the apparatus directing the trafficking of receptor tyrosine kinases from early endosomes to MVBs (68) . Thus, a disturbance of huntingtin might-via HAP1-lead to nonphysiological trafficking of growth factor receptors and signaling. In addition, HIP14 overexpression experiments found evidence that disturbed interaction between huntingtin and HIP14 could contribute to the neuronal dysfunction in Huntington disease by perturbing normal intracellular transport pathways in neurons (67) .
Moreover, results of recent studies suggest that wildtype huntingtin upregulates and that mutant huntingtin directly inhibits transcription of BDNF; the latter effect might be due to the trapping of CREB-binding protein in nuclear inclusions of Huntington disease patients (69) . Thus, striatal neurons might be deprived of neurotrophic support due to diminished expression and reduced anterograde transport in cortical and substantia nigra neurons and because of reduced retrograde transport in dendrites and axons of striatal neurons.
Parkinson disease (PD) is characterized by a progressive loss of dopaminergic neurons of the substantia nigra pars compacta. Mutations in the protein parkin cause a hereditary form of the disease. This protein of 50 kD is found in processes and cell bodies of basal ganglia neurons and has been shown to be a ubiquitin-protein ligase (70, 71) . Significantly, parkin muteins carrying point mutations that are found in patients are defective in this catalytic activity. Another protein both mutated in hereditary PD and involved in ubiquitination is ubiquitin-carboxy terminal hydrolase 1, UCHL1 (72, 73) .
Could there be a link between ubiquitin-attachment and neurotrophin receptor trafficking? Recent studies implicate ubiquitination as a novel and important sorting tag for the internalization and trafficking of receptor tyrosine kinases to MVBs, from where MAPK signaling seems to emerge (42, 74, 75) (Fig. 1) . Thus, ubiquitin-ligases specific for neurotrophin receptors might be interesting candidates for regulation at the interface of trafficking and signaling (76) . No study has yet evaluated whether the ubiquitin-ligase parkin might be competent in terms of TrkB ubiquitination. On a more general note, accumulation of potentially toxic, misfolded, often ubiquitinated proteins is a common feature of neurodegenerative diseases (73) . Besides being ''road blocks'' for the trafficking of trophic factors, these accumulations might affect ubiquitination in a way that is detrimental for trophic factor trafficking and signaling (73, 77) .
Histological hallmarks of AD are extracellular senile plaques and intracellular neurofibrillary tangles in the cerebral cortex. Proteolytic processing of amyloid precursor protein (APP) generates amyloid-␤ peptides (A␤) and has been implicated in the pathogenesis of Alzheimer plaques and AD. The APP gene is located on Chromosome 21 and intriguingly, patients with Down syndrome (Trisomy 21) develop early-onset AD-like disease. Moreover, mutations in APP are associated with familiar AD. Although APP has already been cloned in 1987, its physiological function has remained elusive. In an exciting recent study (78) , it was shown that APP is a linker protein that connects the motor protein kinesin-1 with vesicles containing, among other proteins, TrkA receptors. These vesicles move along microtubules via binding of kinesin-1 and undergo fast anterograde axonal transport. Moreover, A␤ fragments were generated within these vesicles (78) . Kamal and coworkers offered the tantalizing proposal that in AD neurons, Abeta deposits in axonal membrane vesicles could effectively deprive neuronal cell bodies of retrogradely transported survival factors by axonal clogging. This could in theory be the consequence of TrkA not reaching the synapse (block of anterograde transport) or of activated TrkA receptors not reaching the cell body (block of retrograde transport) (78) .
Similar proposals have been made regarding the microtubule-associated protein tau, which is important for the stabilization of microtubules. In AD and other dementias associated with tau pathology such as familial frontotemporal dementia, tau aggregates, accumulates, and loses its stabilizing function. One study found that overexpression of tau in primary neurons blocked kinesin-dependent transport of Golgi apparatus-derived vesicles into neurites. Tau overexpression resulted in the inhibition of anterograde transport of APP causing its accumulation in cell bodies, suggesting a connection between tau and APP trafficking (80) , much in line with the above discussed study.
Presenilins (PS) are transmembrane proteins that play a role in the proteolysis of cell surface proteins, and mutations in PS1 and PS2 are associated with early-onset familiar AD. These proteins have been localized to vesicles in neuronal cell bodies and dendrites, and many groups consider them as essential for the proteolysis of APP giving rise to the above-described amyloidogenic Abeta peptide. Naruse et al described that neurons lacking PS1 not only fail to secrete A␤, but also show diminished functional TrkB receptors, suggesting that alterations of presenilin function could compromise TrkB maturation (81) .
Basal forebrain cholinergic neurons (BFCN) undergo atrophy in AD, a phenotype also observed in NGF knockout mice (14) . These cells express p75NTR, TrkA, and TrkB, whereas the target tissues of their projecting axons express NGF, BDNF, and NT3 (hippocampus and neocortex). Injected iodinated NGF is transported retrogradely from hippocampus or cortex to BFCNs. Moreover, classical experiments (82) showed that the degeneration of BFCN after disruption of target contact (fimbria fornix transsection) can be blocked by infusion of NGF. Also, even though knock-out mice lacking NGF develop only slow degeneration of BFCNs, transgenic mice expressing a function-blocking anti-NGF antibody present with a dramatic neurodegenerative phenotype, including cholinergic deficit, APP deposits and neurofibrillary pathology (83) .
Interestingly, knockout mice lacking p75NTR presented with increased numbers of BFCNs. This could either be explained by p75NTR being a pro-apoptotic receptor (84), or, alternatively, by enhanced signaling of targetderived NT3 via TrkA or BDNF via TrkB receptors, as it is known that the presence of p75NTR might decrease interactions of NT3 with TrkA and of BDNF with TrkB (85, 86) . Given that NGF improves memory performance and BFCN size in aged mammals, these findings altogether point towards NGF playing a role in the pathophysiology of AD and in the physiology of BFCNs in healthy humans. It was mentioned above that patients with Down syndrome develop early-onset AD-like disease. In a remarkable recent paper, Cooper et al examined the retrograde transport of iodinated NGF in a mouse model of Down syndrome (87) . These mice (featuring trisomy of chromosome 16, the murine homologue of human chromosome 21) showed impaired retrograde transport of NGF from the hippocampus to the BFCN. Intracerebroventricular infusion of NGF reversed atrophy of BFCNs and restored deficits in cholinergic innervation. The authors concluded that age-related cholinergic dysfunction may be a treatable disorder of failed retrograde NGF signaling.
Supporting the finding of a decreased retrograde transport of NGF in this disease, Scott et al reported significant increases in cortical NGF associated with decreases in the nucleus basalis Meynert (NBM) in postmortem brains of AD patients (88) . This finding could be interpreted as a sign of decreased retrograde transport of NGF from target tissue (cortex) to cell bodies (NBM). One possibility is that the retrograde transport apparatus is affected. Another possibility is that retrograde transport of NGF is intact but that there is a defect in NGF secretion by target tissues.
What is known about NGF synthesis and release? Several mRNA transcripts of NGF were described, giving rise to 2 different proteins called the short (proNGF) and long isoform (pre-proNGF) (89) . Both isoforms undergo proteolytic cleavage giving rise to mature NGF. No functional significance has yet been attributed to the preproNGF, but in an exciting recent turn Lee et al found that both proNGF and NGF are secreted from transfected cells and that they differ in their interaction with TrkA and p75NTR (90) . NGF showed a higher affinity to TrkA than proNGF, whereas proNGF bound stronger to p75NTR than NGF. The former result is in line with findings by Mowla et al who found that proBDNF does not activate TrkB as efficiently as BDNF (91) . The observation that pro-neurotrophins are less efficient regarding activation of Trk receptors immediately appears relevant for neuronal pathophysiology, as a report by Fahnestock et al recently revealed that only proNGF is found in brain lysates of normal adults and is increased in AD brains (28) . Thus, there seems to be an important and so far disregarded regulation of the proteolytic process of NGF. This process might have an impact on the activation of NGF receptors, favoring the activation of the p75NTR over the TrkA receptor, which might lead to different signaling qualities. However, nothing is known yet on the internalization and retrograde signaling of proNGF or pre-proNGF.
Many studies concluded that neurotrophins undergo ''regulated'' depolarization-dependent release from transfected neuronal cell lines or virus-infected neurons in the central nervous system, including hippocampal neurons. One could imagine that decreased release of NGF from BFCN targets, such as hippocampal neurons, is caused by decreased firing of BFCNs. Thus, decreased depolarization of postsynaptic target neurons would lead to decreased activity-dependent release of NGF and subsequently decreased retrograde transport of presynaptic TrkA receptors. This hypothesis sounds appealing, but will be complicated to address experimentally in vivo. However, both proNGF and NGF undergo regulated secretion in response to depolarization (92) , arguing against a developmental switch in NGF processing as a reason for altered release.
Amyotrophic lateral sclerosis (ALS) is characterized by a selective degeneration of motor neurons. Accumulations of neurofilaments (spheroids) are commonly found in axons of ALS patients. Variant alleles of the neurofilament heavy subunit gene have been detected in cases of ALS, and overexpression of neurofilament protein causes impairment of axonal transport and motor neuron degeneration in transgenic mice (9) . Impairment of axonal transport is also an early consequence of superoxide dismutase mutations that lead to familial ALS (93) . Conceivably, decreased retro-and anterograde transport in motor neurons might contribute to motor neuron degeneration by causing a decisive lack of trophic support.
Treatment Studies
Neurotrophic factors have been applied successfully in animal models of neurodegenerative diseases including motor neuron disease/ALS, PD, and Huntington disease (94) . However, a number of clinical trials mainly in ALS patients that were built on these experiences failed. No significant beneficial effects were recorded, possibly because neurons were not reached by the trophic factors in sufficient quantities upon systemic administration. Severe side effects were recorded especially in the case of CNTF application (94) . To overcome these obstacles, alternative routes of delivery of neurotrophic factors such as lentiviral vectors (95) have been proposed. Possible alternatives are neurotrophin small molecule mimetics or other pharmacological compounds that easily cross the bloodbrain barrier and activate signaling cascades of neurotrophic factors (94, 96) , or as transplanted neuronal stem cells genetically modified to produce neurotrophins (97) .
